Sofia, Bulgaria, January 22, 2024 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (SFA: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for December 2023 the Company recorded a decrease in sales of 57% compared to the same month of the previous year, incl. 27% decrease in domestic sales and 68% decrease in export sales.

For 2023 the revenues from sales of products increase by 7%, incl. 1% increase of sales for the domestic market and 11% increase in export sales.

Sofia, Bulgaria, 15 January 2024 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (SFA: “BSE” AD, SPH: Warsaw Stock Exchange) notifies that the Board of Directors of "Sopharma" AD adopted a decision to initiate a procedure for the merger of the subsidiary "Veta pharma" AD, UIC: 104111084 in "Sopharma" AD under the conditions and in accordance with Chapter XVI of the Commercial Law and Art. 122 of the Law on the Public Offering of Securities. At the start of the procedure Sopharma AD owns 99.98% in the capital of the company.

Sofia, Bulgaria, January 10, 2024 – In accordance with the requirements of art. 100 of LPOS “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on January 22, 2024 the Company will initiate the payment of the dividend for the 6 months of 2023 of 90 stotinki voted on the Extraordinary General Meeting of Shareholders held on November 24, 2023.

The shareholders eligible for dividend are those registered in the book of shareholders 14 days after the date of the EGM on which the distribution of dividend was voted, i.e. December 08, 2023.

Sofia, Bulgaria, December 22 2023 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on December 22, 2023 the Company bought 20 000 (twenty thousand) own shares representing 0.0116% of the share capital of the Company, at a total value of BGN 114 400,00 on the Bulgarian Stock Exchange, the average price per share was BGN 5,72.

Sofia, Bulgaria, December 22 2023 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on December 21, 2023 the Company bought 20 000 (twenty thousand) own shares representing 0.0116% of the share capital of the Company, at a total value of BGN 116 000,00 on the Bulgarian Stock Exchange, the average price per share was BGN 5,80.